Eradication of H. pylori infection in patients allergic to penicillin using triple therapy with a PPI, metronidazole and sitafloxacin

Intern Med. 2014;53(6):571-5. doi: 10.2169/internalmedicine.53.1677.

Abstract

Eradication of H. pylori in patients allergic to penicillin should be performed using regimens without penicillin derivatives. We treated a total of 28 patients allergic to penicillin with a proton pump inhibitor (PPI), metronidazole (250 mg bid) and sitafloxacin (100 mg bid) for one to two weeks. At four to eight weeks after the treatment, the patients underwent the [(13)C]-urea breath test. The overall eradication rate was 100.0%. Mild adverse events were observed. Triple therapy with a PPI, metronidazole and sitafloxacin is well tolerated and effective for the eradication of H. pylori in patients allergic to penicillin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Breath Tests
  • Cytochrome P-450 CYP2C19 / metabolism
  • Drug Administration Schedule
  • Drug Hypersensitivity
  • Drug Therapy, Combination
  • Female
  • Fluoroquinolones / administration & dosage*
  • Genotype
  • Helicobacter Infections / drug therapy*
  • Helicobacter Infections / epidemiology
  • Helicobacter Infections / prevention & control
  • Helicobacter pylori / drug effects*
  • Humans
  • Japan / epidemiology
  • Metronidazole / administration & dosage*
  • Middle Aged
  • Penicillins / immunology
  • Proton Pump Inhibitors / administration & dosage*
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Fluoroquinolones
  • Penicillins
  • Proton Pump Inhibitors
  • Metronidazole
  • sitafloxacin
  • CYP2C19 protein, human
  • Cytochrome P-450 CYP2C19